{"nctId":"NCT04068051","briefTitle":"Multimechanistic Treatment Over Time of Migraine Symptoms (MOVEMENT)","startDateStruct":{"date":"2019-07-06","type":"ACTUAL"},"conditions":["Migraine"],"count":706,"armGroups":[{"label":"AXS-07","type":"EXPERIMENTAL","interventionNames":["Drug: AXS-07"]}],"interventions":[{"name":"AXS-07","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Has participated in a prior study with AXS-07 for the treatment of migraine\n\nExclusion Criteria:\n\n* Has previously received any investigational drug or device or investigational therapy within 30 days before Screening, other than AXS-07\n* Pregnant, breastfeeding, or planning to become pregnant or breastfeed during the study","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","maximumAge":"65 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Long-term Safety of Chronic Intermittent Use of AXS-07","description":"Long-term safety as measured by:\n\nSubjects with any TEAEs\n\nSubjects with suspected to be drug-related TEAEs\n\nSubjects with serious TEAEs\n\nSubjects with TEAEs that led to drug withdrawal\n\nSubjects with TEAEs that led to withdrawal from study\n\nSubjects with TEAEs that resulted in death","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"293","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"118","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"8","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"10","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"13","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":8,"n":706},"commonTop":["Nausea","Vomiting","Dizziness"]}}}